Y
Yujing Wang
Researcher at Queen's University Belfast
Publications - 12
Citations - 192
Yujing Wang is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: Drug delivery & Life expectancy. The author has an hindex of 6, co-authored 12 publications receiving 130 citations. Previous affiliations of Yujing Wang include Maastricht University.
Papers
More filters
Journal ArticleDOI
Microneedles for enhanced transdermal and intraocular drug delivery.
TL;DR: Microneedle‐based transdermal and ocular drug delivery systems have the potential to greatly impact not only patient benefits, but also industry, and through diligence, innovation and collaboration, their true potential will begin to be realised within the next 3–5 years.
Journal ArticleDOI
Posterior drug delivery via periocular route: challenges and opportunities
TL;DR: The challenges and opportunities of posterior segment drug delivery via the periocular route are highlighted, and the importance of understanding complex barrier functions so as to continue to develop innovative drug-delivery systems is envisaged.
Journal ArticleDOI
Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye
Yu Wu,Lalitkumar K. Vora,Yujing Wang,Muhammad Faris Adrianto,Ismaiel Tekko,David Waite,Ryan F. Donnelly,Raghu Raj Singh Thakur +7 more
TL;DR: In this article, a model protein, ovalbumin (OVA)-encapsulated PLGA NPs were prepared and optimized using a water-in-oil-inwater (W/O/W) double emulsion method.
Journal ArticleDOI
Preparation and structure of drug-carrying biodegradable microspheres designed for transarterial chemoembolization therapy
Yujing Wang,Abderazak Benzina,Daniel G. M. Molin,Nynke M. S. van den Akker,Mick Gagliardi,Leo H. Koole +5 more
TL;DR: This work provides a useful approach for the fabrication of drug-eluting beads used in transarterial chemoembolization by providing in vitro cytotoxicity experiments and classical matrigel endothelial tube assay certificated the maintaining bioactivity of cisplatin and sorafenib tosylate released from the microspheres, respectively.
Journal ArticleDOI
In vitro and in vivo evaluation of drug-eluting microspheres designed for transarterial chemoembolization therapy.
Yujing Wang,Daniel G. M. Molin,Chantal Sevrin,Christian Grandfils,Nynke M. S. van den Akker,Mick Gagliardi,Menno L. W. Knetsch,Tammo Delhaas,Levinus Koole,Levinus Koole +9 more
TL;DR: This study demonstrates the applicability of biodegradable poly(D,L-lactic acid) microspheres loaded with cisplatin and sorafenib tosylate for local drug delivery as well as the potential of thesemicrospheres for future use in transarterial chemoembolization.